JNJ•benzinga•
Johnson & Johnson Presents Icotrokinra Results Showing 75% Of Adolescents With Plaque Psoriasis Achieved Completely Clear Skin And Demonstrate Favorable Safety Profile In A Once Daily Pill
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga